Could drug holidays extend prostate cancer control?
NCT ID NCT02415621
Summary
This small, early study is testing a new way to take the prostate cancer drug abiraterone. It aims to see if stopping the drug when PSA levels drop, and restarting only when they rise again, can help control the cancer longer while keeping patients feeling well enough for daily activities. The study is enrolling men whose cancer has spread and is no longer responding to standard hormone therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.